Academic Staff


Assoc. Prof. Dr. Arthorn Riewpaiboon

Assoc. Prof. Dr. Arthorn Riewpaiboon

arthorn.rie@mahidol.ac.th

arthorn.rie@mahidol.ac.th
Department of Pharmacy, Faculty of Pharmacy, Mahidol University.

General Information

Education:
  • B Pharm, 1981, Mahidol University, Thailand.
  • MSc in Pharm (Pharmacognosy), 1988, Chulalongkorn University, Thailand.
  • PhD (Pharmacy/Pharmacoeconomics), 1998, Curtin University of Technology, Western Australia.


Area of Interest:

·      Hospital cost analysis

·      Cost analysis of healthcare program

·      Cost of illness studies

·      Health economic evaluation

Focusing on

·      Vaccination

·      Vaccine preventable diseases (VPDs)

·      Non communicable diseases (NCDs)




Research:

1. Cost analysis of health promotion and disease prevention in Thailand

2.  Cost of traditional medicine in Thailand

3. Development of costing manual for health promotion in community

4. Development of guidance on hospital cost analysis in Indonesia

5. The costs of preparation and delivery of Td vaccine to 7-4 year-old children in Vietnam

6. Economic analysis of rotavirus vaccination program in pilot province, Thailand



Awards and Experience:

Award:

High quality research award from the 6th Vaccine and ISV Annual Global Congress, Shanghai, 14-16 Octiber 2012

Professional experiences:

1)        World Health Organization’s short term consultant.

2)        Principal investigator: Micro-costing study of influenza vaccination for pregnant women in Thailand. Task Force for Global Health, Inc. (TFGH).

3)        Principal investigator: Cost analysis of health promotion and disease prevention. National Health Security Office. Thailand.

4)        Principal investigator: Development of costing manual of health promotion in community. Thai Health Promotion Foundation. 

5)        Editorial board of International Journal of Pharmacy Practice, Pharmaceutical Press, London, UK.

6)        Editorial board of Mahidol University Journal of Pharmaceutical Sciences

7)        Consultant: Costing analysis of Human papillomavirus (HPV) pilot vaccination in Lao PDR. WHO-WPRO.

8)        Consultant: Cost analysis of Human papillomavirus (HPV) scale-up vaccination in Lao PDR. WHO-WPRO.

9)        Consultant: Cost analysis of Human papillomavirus (HPV) vaccination in Bhutan. WHO-SEARO.

10)    Consultant: Economic evidence for decision makers in Cambodia, Thailand and Vietnam. Dengue Vaccine Initiative: International Vaccine Institute, Seoul, Korea.

11)    Consultant: Division of Translational Research, International Vaccine Institute, Seoul, Korea.

12)    Consultant: Economic analysis of a hypothetical intensified rabies prevention and control program in Vietnam. WHO-WIPRO.

13)    Principal investigator of the Vaccine supply chain and logistics system in Thailand sponsored by the Project Optimize, a joint program of WHO and PATH.

14)    Consultant: Economic evaluation of “An open label randomized   comparison of injectable artesunate and quinine in children with severe falciparum malaria in Africa (AQUAMAT)” funded by the Wellcome Trust, UK. 

15)    Principal investigator: Development of standard cost lists for health technology assessment of Thailand. Sponsored by HITAP, Ministry of Public Health.

16)    Consultant: DOMI program (Cholera, Shigella, typhoid) in Bangladesh, China, India, Indonesia, Mozambique and Vietnam, sponsored by the International Vaccine Institute.




General Information Publication Presentation Related News

Faculty of Pharmacy, Mahidol University.

447 Sri-Ayuthaya Road, Rajathevi, Bangkok 10400, THAILAND
Designed & Developed by Department of Information Technology, Faculty of Pharmacy, Mahidol University.
Copyright © 2013-2020